However, in marked contrast with RTKs involved in cancer progression such as epidermal growth factor receptor (EGFR) and mesenchymal-to-epithelial transition, little is known about the specific mechanisms induced upon AXL activation to promote tumor invasiveness, metastasis, and other features, such as drug resistance. Here, EGFR is linked to cancer.